X0306 4 2021-01-28 1 0001481646 Accolade, Inc. ACCD 0001200675 BRONFMAN EDGAR JR C/O ACCRETIVE, LLC, 660 MADISON AVENUE, 12TH FLOOR, SUITE 1215 NEW YORK NY 10065 0 0 0 1 Former 10% Owner Common Stock 2021-01-28 4 J 0 128961 D 0 I By Accretive Care Holding Partnership Common Stock 2021-01-28 4 J 0 138 A 138 D Common Stock 2021-01-28 4 J 0 1130221 D 0 I By Accretive Coinvestment Partners, LLC Common Stock 2021-01-28 4 J 0 155118 A 155256 D Common Stock 2021-01-28 4 J 0 1076796 D 0 I By Accretive II Coinvestment, L.P. Common Stock 2021-01-28 4 J 0 210622 A 365878 D Common Stock 2021-01-28 4 J 0 3293683 D 0 I By Accretive II, L.P. Common Stock 2021-01-28 4 J 0 9271 A 375149 D Common Stock 2021-01-28 4 J 0 4499447 D 0 I By Accretive Investors SBIC, L.P. Common Stock 2021-01-28 4 J 0 577177 A 952326 D On January 28, 2021, 128,961 shares of common stock of Accolade, Inc. ("Common Stock") held of record by Accretive Care Holding Partnership ("ACHP") were distributed to the entity's partners on a pro rata basis for no consideration. ACHP no longer holds any shares of Common Stock. The Reporting Person and J. Michael Cline are the managing members of Accretive II GP, LLC, the general partner of ACHP, and may have been deemed to have shared voting and dispositive power with respect to the shares of Common Stock previously held by ACHP. Also on January 28, 2021, Accretive II GP, LLC further distributed to its members, on a pro rata basis, for no consideration, all of the shares of Common Stock received by it in the distribution from ACHP. As part of such distribution, Mr. Bronfman, Jr. received 138 shares of Common Stock previously held by ACHP. On January 28, 2021, 1,130,221 shares of Common Stock held of record by Accretive Coinvestment Partners, LLC ("ACP") were distributed to the entity's members on a pro rata basis for no consideration. ACP no longer holds any shares of Common Stock. The Reporting Person and J. Michael Cline are the managing members of Accretive Associates I, LLC, the managing member of ACP, and may have been deemed to have shared voting and dispositive power with respect to the shares previously held by ACP. Also on January 28, 2021, Accretive Associates I, LLC and other partners of ACP further distributed to their respective members, on a pro rata basis, for no consideration, all of the shares of Common Stock received by them in the distribution from ACP. As part of such distribution, Mr. Bronfman, Jr. received 155,118 shares of Common Stock previously held by ACP. On January 28, 2021, 1,076,796 shares of Common Stock held of record by Accretive II Coinvestment, L.P. ("AIIC") were distributed to the entity's partners on a pro rata basis for no consideration. AIIC no longer holds any shares of Common Stock. The Reporting Person and J. Michael Cline are the managing members of Accretive II GP, LLC, the general partner of AIIC, and may have been deemed to have shared voting and dispositive power with respect to the shares of Common Stock previously held by AIIC. Also on January 28, 2021, Accretive II GP, LLC and other partners of AIIC further distributed to their respective members, on a pro rata basis, for no consideration, all of the shares of Common Stock received by them in the distribution from AIIC. As part of such distribution, Mr. Bronfman, Jr. received 210,622 shares of Common Stock previously held by AIIC. On January 28, 2021, 3,293,683 shares of Common Stock held of record by Accretive II, L.P. were distributed to the entity's partners on a pro rata basis for no consideration. Accretive II, L.P. no longer holds any shares of Common Stock. The Reporting Person and J. Michael Cline are the managing members of Accretive II GP, LLC, the general partner of Accretive II, L.P., and may have been deemed to have shared voting and dispositive power with respect to the shares of Common Stock previously held by Accretive II, L.P. Also on January 28, 2021, Accretive II GP, LLC further distributed to its members, on a pro rata basis, for no consideration, all of the shares of Common Stock received by it in the distribution from Accretive II, L.P. As part of such distribution, Mr. Bronfman, Jr. received 9,271 shares of Common Stock previously held by Accretive II, L.P. On January 28, 2021, 4,499,447 shares of Common Stock held of record by Accretive Investors SBIC, L.P. ("SBIC") were distributed to the entity's partners on a pro rata basis for no consideration. SBIC no longer holds any shares of Common Stock. The Reporting Person and J. Michael Cline are the managing members of Accretive Associates SBIC, LLC, the general partner of SBIC and may have been deemed to have shared voting and dispositive power with respect to the shares of Common Stock previously held by SBIC. Also on January 28, 2021, Accretive Associates SBIC, LLC and other partners of SBIC further distributed to their respective members, on a pro rata basis, for no consideration, all of the shares of Common Stock received by them in the distribution from SBIC. As part of such distribution, Mr. Bronfman, Jr. received 577,177 shares of Common Stock previously held by SBIC. /s/ Edgar Bronfman, Jr. 2021-02-01